Suchergebnisse - "Pogue, Jason M"

PubPharm (223)

71

The Hypothetical Impact of Accelerate Pheno on Time to Effective Therapy and Time to Definitive Therapy for Bloodstream Infections Due to Drug-Resistant Gram-Negative Bacilli

enthalten in: Antimicrobial agents and chemotherapy | 2019

von Henig, O. | Kaye, K. | Chandramohan, S. | +5

72

Plazomicin : A Novel Aminoglycoside for the Treatment of Resistant Gram-Negative Bacterial Infections

enthalten in: Drugs | 2019

von Eljaaly, K. | Alharbi, A. | Alshehri, S. | +2

73

Plazomicin: A Novel Aminoglycoside for the Treatment of Resistant Gram-Negative Bacterial Infections

enthalten in: Drugs | 2019

von Eljaaly, K. | Alharbi, A. | Alshehri, S. | +2

74

Plazomicin: A Novel Aminoglycoside for the Treatment of Resistant Gram-Negative Bacterial Infections

enthalten in: Drugs | 2019

von Eljaaly, K. | Alharbi, A. | Alshehri, S. | +2

75

Toxicity in Patients

enthalten in: Advances in experimental medicine and biology | 2019

von Pogue, J. | Tam, V.

76

International Consensus Guidelines for the Optimal Use of the Polymyxins : Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)

enthalten in: Pharmacotherapy | 2019

von Tsuji, B. | Pogue, J. | Zavascki, A. | +15

CommentIn: Pharmacotherapy. 2019 Jan;39(1):7-9. - PMID 30623457

77

Ceftazidime/Avibactam, Meropenem/Vaborbactam, or Both? Clinical and Formulary Considerations

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2019

von Pogue, J. | Bonomo, R. | Kaye, K.

78

The hypothetical impact of Accelerate Pheno™ system on time to effective therapy and time to definitive therapy in an institution with an established antimicrobial stewardship programme currently utilizing rapid genotypic organism/resistance marker identification

enthalten in: The Journal of antimicrobial chemotherapy | 2019

von Henig, O. | Cooper, C. | Kaye, K. | +9

79

Making the change to area under the curve-based vancomycin dosing

enthalten in: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists | 2018

von Heil, E. | Claeys, K. | Mynatt, R. | +5

CommentIn: Am J Health Syst Pharm. 2019 Oct 15;76(21):1718-1721. - PMID 31612932

80

Averting the post-antibiotic era : successful use of meropenem/vaborbactam for carbapenem-resistant Serratia marcescens and Enterobacter aerogenes bacteraemia in a haemodialysis patient

enthalten in: The Journal of antimicrobial chemotherapy | 2018

von Jorgensen, S. | McDonald, P. | Mynatt, R. | +5